CRYOPORT, INC. Unusual or Infrequent Item, or Both, Loss, Gross
CRYOPORT, INC. (CYRX) had Unusual or Infrequent Item, or Both, Loss, Gross of $9.40 million as of 2022-01-25, per its 10-K filed 2025-03-07.
Financial Statements › Notes › Unusual or Infrequent Item, or Both, Net of Insurance Proceeds
us-gaap:UnusualOrInfrequentItemLossGross · last filed 2025-03-07
- 2022-01-25: Unusual or Infrequent Item, or Both, Loss, Gross $9.40M.
| Period end | Unusual or Infrequent Item, or Both, Loss, Gross |
|---|---|
| 2022-01-25 | $9.40M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |